Neurologic complications associated with the Zika virus in Brazilian adults

JAMA Neurology

Volumn 74, Issue 10, 2017, Pages 1190-1198

  Da Silva, Ivan Rocha Ferreira ^a,b   Frontera, Jennifer A ^c   De Filippis, Ana Maria Bispo ^d   Do Nascimento, Osvaldo Jose Moreira ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b Neurocritical Care Department   (Brazil)

^c NEW YORK UNIVERSITY   (United States)

^d INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRAZIL; BRAZILIAN; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC PAIN; CLINICAL ARTICLE; COHORT ANALYSIS; DEATH; ELECTROMYOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN BARRE SYNDROME; HOSPITAL ADMISSION; HUMAN; INFECTION RATE; INTENSIVE CARE UNIT; MALE; MENINGOENCEPHALITIS; MYELITIS; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANKIN SCALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVOR; ZIKA FEVER; COMPLICATION; ENCEPHALITIS; GENETICS; GUILLAIN-BARRE SYNDROME; INCIDENCE; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOGENICITY; VIROLOGY; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

ADULT; AGED; BRAZIL; COHORT STUDIES; ELECTROMYOGRAPHY; ENCEPHALITIS; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; MALE; MIDDLE AGED; YOUNG ADULT; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85031792790     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2017.1703     Document Type: Article

References (40)

1. Pan American Health Organization, World Health Organization. Epidemiologic update: neurological syndrome, congenital anomalies, and Zika virus infection. http://www.paho.org/hq/index.php?option=com_docman&task=doc_view&Itemid=270&gid=32879&lang=en. Published January 17, 2016. Accessed July 17, 2016.
2. Secretaria de Vigilância em Saúde—Ministério da Saúde. Boletim epidemiológico. http://portalarquivos.saude.gov.br/images/pdf/2016 /julho/15/2016-boletim-epi-n28-dengue-chik-zika-se23.pdf. Accessed July 17, 2016.
3. Araujo AQ, Silva MT, Araujo AP. Zika virus-associated neurological disorders: a review. Brain. 2016;139(pt 8):2122-2130.
4. Centers for Disease Control and Prevention. Florida investigation links four recent Zika cases to local mosquito-borne virus transmission. https://www.cdc.gov/media/releases/2016/p0729-florida-zika-cases.html. Published July 29, 2016. Accessed July 30, 2016.
5. World Health Organization. Guillain-Barré syndrome—Brazil. http://www.who.int/csr/don/8-february-2016-gbs-brazil/en/. Accessed July 17, 2016.
6. Cao-Lormeau VM, Blake A, Mons S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387(10027): 1531-1539.
7. Parra B, Lizarazo J, Jiménez-Arango JA, et al. Guillain-Barré syndrome associated with Zika virus infection in Colombia. N Engl J Med. 2016;375(16): 1513-1523.
8. Carteaux G, Maquart M, Bedet A, et al. Zika virus associated with meningoencephalitis. N Engl J Med. 2016;374(16):1595-1596.
9. Mécharles S, Herrmann C, Poullain P, et al. Acute myelitis due to Zika virus infection. Lancet. 2016; 387(10026):1481.
10. Furtado JM, Espósito DL, Klein TM, Teixeira-Pinto T, da Fonseca BA. Uveitis associated with Zika virus infection. N Engl J Med. 2016;375(4): 394-396.
11. Ferreira da Silva IR, Frontera JA, Moreira do Nascimento OJ. News from the battlefront: Zika virus–associated Guillain-Barré syndrome in Brazil. Neurology. 2016;87(15):e180-e181.
12. Sejvar JJ, Kohl KS, Gidudu J, et al; Brighton Collaboration GBS Working Group. Guillain-Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2011;29(3):599-612.
13. World Health Organization. Laboratory testing for Zika virus infection. http://apps.who.int/iris/bitstream/10665/204671/1/WHO_ZIKV_LAB_16.1_eng.pdf?ua=1. Published March 23, 2016. Accessed July 17, 2016.
14. Lanciotti RS, Kosoy OL, Laven JJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14(8): 1232-1239.
15. Cordeiro MT, Pena LJ, Brito CA, Gil LH, Marques ET. Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil. Lancet. 2016;387(10030): 1811-1812.
16. Tunkel AR, Glaser CA, Bloch KC, et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2008;47(3):303-327.
17. Centers for Disease Control and Prevention. Fact sheet for healthcare providers: interpreting Zika MAC-ELISA test results. https://www.cdc.gov/zika/pdfs/interpreting-zika-mac-elisa-results.pdf. Accessed April 13, 2017.
18. Hadden RD, Cornblath DR, Hughes RA, et al; Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol. 1998;44(5): 780-788.
19. Hughes RA, Cornblath DR. Guillain-Barré syndrome. Lancet. 2005;366(9497):1653-1666.
20. Van der Meché FG, Van Doorn PA, Meulstee J, Jennekens FG; GBS-consensus group of the Dutch Neuromuscular Research Support Centre. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur Neurol. 2001;45(3): 133-139.
21. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014;137(Pt 1):33-43.
22. Kalita J, Misra UK, Das M. Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2008;79(3):289-293.
23. Wakerley BR, Uncini A, Yuki N; GBS Classification Group; GBS Classification Group. Guillain-Barré and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol. 2014;10 (9):537-544.
24. Scott TF, Frohman EM, De Seze J, Gronseth GS, Weinshenker BG; Therapeutics and Technology Assessment Subcommittee of American Academy of Neurology. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2011;77(24): 2128-2134.
25. Venkatesan A, Tunkel AR, Bloch KC, et al; International Encephalitis Consortium. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114-1128.
26. Sander HW, Latov N. Research criteria for defining patients with CIDP. Neurology. 2003;60 (8)(suppl 3):S8-S15.
27. Yuki N, Kokubun N, Kuwabara S, et al. Guillain-Barré syndrome associated with normal or exaggerated tendon reflexes. J Neurol. 2012;259 (6):1181-1190.
28. Van den Bergh PY, Hadden RD, Bouche P, et al; European Federation of Neurological Societies; Peripheral Nerve Society. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision. Eur J Neurol. 2010;17(3): 356-363.
29. Bingham AM, Cone M, Mock V, et al. Comparison of test results for Zika virus RNA in urine, serum, and saliva specimens from persons with travel-associated Zika virus disease—Florida, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(18): 475-478.
30. Mansfield KL, Horton DL, Johnson N, et al. Flavivirus-induced antibody cross-reactivity. J Gen Virol. 2011;92(Pt 12):2821-2829.
31. Centers for Disease Control and Prevention. Update on interim Zika virus clinical guidance and recommendations. https://emergency.cdc.gov/coca/ppt/2016/03_3_16_zika_update.pdf. Published February 25, 2016. Accessed July 17, 2016.
32. Cordeiro MT, Brito CA, Pena LJ, et al. Results of a Zika Virus (ZIKV) immunoglobulin M–specific diagnostic assay are highly correlated with detection of neutralizing anti-ZIKV antibodies in neonates with congenital disease. J Infect Dis. 2016; 214(12):1897-1904.
33. Frontera JA, da Silva IR. Zika getting on your nerves? the association with the Guillain-Barré syndrome. N Engl J Med. 2016;375 (16):1581-1582.
34. Brasil P, Sequeira PC, Freitas AD, et al. Guillain-Barré syndrome associated with Zika virus infection. Lancet. 2016;387(10026):1482.
35. Zambrano H, Waggoner JJ, Almeida C, Rivera L, Benjamin JQ, Pinsky BA. Zika virus and Chikungunya virus coinfections: a series of three cases from a single center in Ecuador. Am J Trop Med Hyg. 2016;95(4):894-896.
36. Rozé B, Najioullah F, Signate A, et al; Neuro-Zika Working Group of Martinique. Zika virus detection in cerebrospinal fluid from two patients with encephalopathy, Martinique, February 2016. [published online April 21, 2016]. Euro Surveill. 2016;21(16). doi:10.2807/1560-7917.ES.2016.21.16.30205
37. Mulkey SB, Glasier CM, El-Nabbout B, et al. Nerve root enhancement on spinal MRI in pediatric Guillain-Barré syndrome. Pediatr Neurol. 2010;43 (4):263-269.
38. Jeha LE, Sila CA, Lederman RJ, Prayson RA, Isada CM, Gordon SM. West Nile virus infection: a new acute paralytic illness. Neurology. 2003;61(1): 55-59.
39. Xiang JY, Zhang YH, Tan ZR, Huang J, Zhao YW. Guillain-Barré syndrome associated with Japanese encephalitis virus infection in China. Viral Immunol. 2014;27(8):418-420.
40. Brecher K, Hochberg FH, Louis DN, de la Monte S, Riskind P. Case report of unusual leukoencephalopathy preceding primary CNS lymphoma. J Neurol Neurosurg Psychiatry. 1998;65 (6):917-920.